Press release
Glycated Haemoglobin Testing Market Estimated to Record Highest CAGR by 2020
To view complete report @ http://www.persistencemarketresearch.com/market-research/glycated-haemoglobin-testing-market.asp
North America dominates the global market for glycated haemoglobin testing due high diabetic prevalence and easily accessible modern healthcare facilities. Asia Pacific followed by the Europe is expected to show high growth rates in the next five years in global glycated haemoglobin testing market. Some of the key driving forces for glycated haemoglobin testing market in emerging countries are increasing prevalence of diabetics and increasing awareness about diabetics.
A sample of this report is available upon request @ www.persistencemarketresearch.com/samples/3219
In recent times there is increased use of glycated haemoglobin testing due to increasing incidence of diabetics among the population. Growing awareness of haemoglobin A1c testing among patients and medical practitioners and aging population are some of the key factors driving the growth for global glycated haemoglobin testing market. In addition, increasing healthcare awareness is also fuelling the growth of global glycated haemoglobin testing market. However, presences of substitutes such as test strips, glucose meters, lancets and continuous blood glucose meter for monitoring diabetes and high test cost are some of the major factors restraining the growth for global glycated haemoglobin testing market.
Increasing healthcare facilities would lead to growth in glycated haemoglobin testing market in Asia. In addition, rapid commercialization of devices for diabetes testing would develop opportunity for global glycated haemoglobin testing market. However, presence of limited approval for assay of glycated haemoglobin testing could lead a challenge for global glycated haemoglobin testing market.
Some of the trends for global glycated haemoglobin testing market are increasing mergers and acquisitions, which would help in improving measurement of glycated haemoglobin and point of care haemoglobin A1c testing.
To view TOC of this report is available upon request @ www.persistencemarketresearch.com/toc/3219
Some of the major companies operating in the global glycated haemoglobin testing market are Abbott Laboratories, Roche Holdings AG, Alere Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Bayer AG, ARKRAY Inc., Randox Laboratories Ltd., Tosoh Corp. and A. Menarini Diagnostics Ltd.
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA - Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Glycated Haemoglobin Testing Market Estimated to Record Highest CAGR by 2020 here
News-ID: 582169 • Views: …
More Releases from Persistence Market Research
HIV AIDS Testing Market Sales Estimated to Hit USD 6.6 Billion by 2032| Says Per …
Introduction
The HIV AIDS testing market has gained significant importance in recent years due to the global focus on early diagnosis, prevention, and management of HIV infections. Timely and accurate testing plays a crucial role in reducing transmission rates, improving patient outcomes, and supporting public health initiatives worldwide. With advancements in diagnostics, including rapid tests, ELISA, and molecular assays, HIV testing has become more accessible, reliable, and efficient across healthcare settings.
For…
Urinary Catheters Market to Surge at 5.6% CAGR, Hitting US$ 3.1 Bn by 2032, Acco …
Introduction
The urinary catheters market has witnessed significant growth in recent years, driven by its essential role in managing urinary retention, incontinence, surgical interventions, and other urological disorders. Urinary catheters are widely used across hospitals, long-term care facilities, and home healthcare settings due to their effectiveness in draining urine from the bladder and supporting patients with chronic or temporary urinary complications. Known for their clinical importance, adaptability, and availability in various…
3D Bioprinting Market Size is Expected to Reach 7.39 Billion by 2032, Rising at …
Introduction
The 3D bioprinting market has gained significant momentum in recent years due to its transformative potential in healthcare, pharmaceutical research, and regenerative medicine. Known for its ability to precisely fabricate complex biological structures, 3D bioprinting is widely applied in areas such as tissue engineering, organ regeneration, drug testing, and personalized medicine. By enabling the creation of living tissues with high accuracy, this technology is revolutionizing research capabilities and paving the…
Viral Molecular Diagnostic Market to Grow at a CAGR of 9.0% from 2025 to 2032, r …
Introduction
The viral molecular diagnostic market has gained substantial traction in recent years due to its critical role in the accurate detection and management of viral infections. Known for their precision, speed, and ability to identify genetic material of viruses, molecular diagnostic tests are widely used across healthcare facilities, research laboratories, and point-of-care settings. These diagnostics provide effective solutions for early disease detection, monitoring of treatment efficacy, and outbreak control, ensuring…
More Releases for Haemoglobin
Glycated Haemoglobin Testing Market to Reach USD 6.2 Billion by 2034
The global burden of diabetes is increasing at an unprecedented rate, and effective monitoring of blood glucose levels has become critical in managing this chronic disease. Among the most reliable tools in diabetes care is glycated haemoglobin (HbA1c) testing, which measures average blood sugar levels over two to three months. Unlike daily glucose monitoring, HbA1c testing provides a long-term perspective, making it a gold standard for diagnosing and managing diabetes.
Download…
Haemoglobin Production Cost Report by Procurement Resource
Procurement Resource, a global leader in procurement intelligence and market analysis, is pleased to release its latest Haemoglobin Production Cost Report-a strategic tool for companies, researchers, investors, and healthcare manufacturers looking to explore or expand haemoglobin production capabilities.
This detailed report delves into the technical, economic, and regulatory aspects of haemoglobin production, offering stakeholders a clear view of cost structures, raw material requirements, production routes, infrastructure, and profitability. With the growing…
Glycated Haemoglobin Testing Equipment Market Size 2024 to 2031.
Market Overview and Report Coverage
Glycated Haemoglobin Testing Equipment is used to measure the level of glycated hemoglobin in the blood, which is a crucial indicator for managing diabetes. The market for glycated haemoglobin testing equipment is expected to witness significant growth in the coming years, with a projected CAGR of 8.60% during the forecasted period.
The increasing prevalence of diabetes worldwide, coupled with the rising awareness about the…
Global Glycated Haemoglobin Testing Market
The Glycated Haemoglobin Testing Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Haemoglobin is the red protein in blood cells which carry oxygen around the body. Haemoglobin A1c is a chemical form of glycated haemoglobin in order to test glucose level in…
Analysis of Global Glycated Haemoglobin Testing Market by 2020
Haemoglobin is the red protein in blood cells which carry oxygen around the body. Haemoglobin A1c is a chemical form of glycated haemoglobin in order to test glucose level in the patients. Glycated haemoglobin test is used for diagnosis and monitoring of Haemoglobin A1c levels in diabetic patient. Glycated haemoglobin test reflects the average amount of glucose for the past 2 to 3 months in diabetic patients. It helps to…
Market study on expected growth for Glycated Haemoglobin Testing by 2020
Haemoglobin is the red protein in blood cells which carry oxygen around the body. Haemoglobin A1c is a chemical form of glycated haemoglobin in order to test glucose level in the patients. Glycated haemoglobin test is used for diagnosis and monitoring of Haemoglobin A1c levels in diabetic patient. Glycated haemoglobin test reflects the average amount of glucose for the past 2 to 3 months in diabetic patients. It helps to…
